Home | Welcome to Contract Pharma   
Last Updated Sunday, March 1 2015

Print

Breaking News

May 23, 2014
Gains early- and mid-stage assets in major therapeutic categories  Read More »
May 23, 2014
Despite CHMP opinion, companies will pursue multiple sclerosis indication  Read More »
May 23, 2014
MyTrials aims to increase patient safety, reduce costs  Read More »
May 21, 2014
Rivipansel moves to Phase III development  Read More »
May 21, 2014
Suzhou site successfully passes three GLP inspections  Read More »
May 21, 2014
To supply Ampligen and Alferon N to Latin American market   Read More »
May 20, 2014
Secures additional manufacturing capacity for Patiromer  Read More »
May 20, 2014
McSorley and Zunggeemoge take on management roles  Read More »
May 20, 2014
Enhances lean manufacturing platform  Read More »
May 20, 2014
Wipro to build and maintain an "as-a-service" global platform  Read More »
May 20, 2014
Expands global market access offerings  Read More »
May 20, 2014
Cunningham brings manufacturing, logistics and supply chain expertise  Read More »
May 20, 2014
To expand and upgrade facilities in Switzerland, U.S. and Germany  Read More »
May 19, 2014
Gains small molecules to potentially cure HBV infections  Read More »
May 19, 2014
To employ AntiOp’s nasal drug delivery expertise  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On